Clinical and research tests for C0684249 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 43

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
KRAS Mutation Analysis PathGroup United States	13	1	T Targeted variant analysis
Inherited Bone Marrow Failure Panel PreventionGenetics, part of Exact Sciences United States	267	186	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Autism Spectrum Disorders (ASD) Panel PreventionGenetics, part of Exact Sciences United States	224	170	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Top 99 Genetic Causes of Developmental Delay Panel PreventionGenetics, part of Exact Sciences United States	170	99	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
KRAS, BRAF, and NRA Mutation Analysis PathGroup United States	23	3	T Targeted variant analysis
BRAF and MSI Mutation Analysis PathGroup United States	15	1	I Microsatellite instability testing (MSI) T Targeted variant analysis
KRAS, BRAF, NRAS and MSI Mutation Analysis PathGroup United States	23	3	T Targeted variant analysis
BRAF, NRAS, KIT Mutation Analysis PathGroup United States	16	3	T Targeted variant analysis
BRAF, EGFR, KRAS Mutation Analysis PathGroup United States	25	3	T Targeted variant analysis
Basic Lung Profile PathGroup United States	15	2	T Targeted variant analysis
PrimBio Cancer HotSpot Panel PrimBio Research Institute United States	60	50	T Targeted variant analysis
Hypomagnesemia Panel PreventionGenetics, part of Exact Sciences United States	16	16	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Comprehensive Panel for Individualized Cancer Threatment GeneKor MSA Greece	16	52	D Deletion/duplication analysis X Mutation scanning of select exons E Sequence analysis of select exons T Targeted variant analysis
BRAF Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States	4	1	T Targeted variant analysis
BRAF Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States	4	1	T Targeted variant analysis
Lung Cancer Susceptibility via the EGFR Gene PreventionGenetics, part of Exact Sciences United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
EGFR 29 mutations GENOTYPOS MSA Greece	1	1	T Targeted variant analysis
PD-L1 28-8 pharmDx by Immunohistochemistry with Interpretation, nivolumab (OPDIVO) Baylor Genetics United States	1	1	T Targeted variant analysis
EGFR Mutation Detection by Pyrosequencing Baylor Genetics United States	1	1	T Targeted variant analysis
PD-L1 22C3 IHC for NSCLC by Immunohistochemistry with Interpretation, Pembrolizumab (KEYTRUDA) Baylor Genetics United States	1	1	T Targeted variant analysis

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 43

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.